MiR-17-5p regulates cell proliferation and migration by targeting transforming growth factor-β receptor 2 in gastric cancer

TGFBR2 serves as an initial regulator of the TGF-β signaling pathway, and loss or reduction of its expression leads to uncontrolled cell growth and invasion. TGFBR2 plays a crucial role in the carcinogenesis and malignant process of gastric cancer, but the mechanism remains unclear. In this study, we found that TGFBR2 protein levels were consistently upregulated in gastric cancer tissues, whereas TGFBR2 mRNA levels varied among these tissues, indicating that a post-transcriptional mechanism is involved in the regulation of TGFBR2. MiRNAs are known to regulate gene expression at the post-transcriptional level. Therefore, we performed bioinformatics analyses to search for miRNAs potentially targeting TGFBR2. MiR-17-5p was found to bind to the 3′UTR of TGFBR2 mRNA, and further validation of this specific binding was performed through a reporter assay. An inverse correlation between miR-17-5p and TGFBR2 protein was observed in gastric cancer tissues. Cell studies revealed that miR-17-5p negatively regulated TGFBR2 expression by directly binding to the 3′UTR of TGFBR2 mRNA, thereby promoting cell growth and migration. We also validated the role of TGFBR2 using siRNA and an overexpression plasmid. The results of our study suggest a novel regulatory network in gastric cancer mediated by miR-17-5p and TGFBR2 and may indicate that TGFBR2 could serve as a new therapeutic target in gastric cancer.

[1]  Xiaoming Fan,et al.  miR-21 inhibits the effects of cyclooxygenase-2 inhibitor NS398 on apoptosis and invasion in gastric cancer cells , 2015, OncoTargets and therapy.

[2]  J. Araya,et al.  miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway , 2015, Cellular Oncology.

[3]  M. V. Dinther,et al.  Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2 , 2015 .

[4]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[5]  V. del Vescovo,et al.  microRNA and Lung Cancer. , 2015, Advances in experimental medicine and biology.

[6]  Zebo Huang,et al.  Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2 , 2015, Tumor Biology.

[7]  Sung-Bae Kim,et al.  NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer , 2014, Breast Cancer Research and Treatment.

[8]  Zhongchan Sun,et al.  In vivo multimodality imaging of miRNA-16 iron nanoparticle reversing drug resistance to chemotherapy in a mouse gastric cancer model. , 2014, Nanoscale.

[9]  Xiaojun Liu,et al.  Matrine alters microRNA expression profiles in SGC-7901 human gastric cancer cells. , 2014, Oncology reports.

[10]  Qiong Wang,et al.  Transforming growth factor-β (TGF-β) induces the expression of chondrogenesis-related genes through TGF-β receptor II (TGFRII)-AKT-mTOR signaling in primary cultured mouse precartilaginous stem cells. , 2014, Biochemical and biophysical research communications.

[11]  F. Kisseljov MicroRNAs and cancer , 2014, Molecular Biology.

[12]  K. Yanagihara,et al.  MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer , 2014, Cancer science.

[13]  P. ten Dijke,et al.  Signaling interplay between transforming growth factor-β receptor and PI3K/AKT pathways in cancer. , 2013, Trends in biochemical sciences.

[14]  Bin Cheng,et al.  MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2. , 2013, World journal of gastroenterology.

[15]  Ji-Lin Wang,et al.  Candidate microRNA Biomarkers in Human Gastric Cancer: A Systematic Review and Validation Study , 2013, PloS one.

[16]  Hua Yang,et al.  Involvement of miR-20a in Promoting Gastric Cancer Progression by Targeting Early Growth Response 2 (EGR2) , 2013, International journal of molecular sciences.

[17]  Xiyun Ye,et al.  Both ERK/MAPK and TGF-Beta/Smad Signaling Pathways Play a Role in the Kidney Fibrosis of Diabetic Mice Accelerated by Blood Glucose Fluctuation , 2013, Journal of diabetes research.

[18]  B. Zhivotovsky,et al.  miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence , 2012, British Journal of Cancer.

[19]  J.,et al.  The New England Journal of Medicine , 2012 .

[20]  Rong-liang Shi,et al.  miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. , 2011, Cancer genetics.

[21]  Chen Huang,et al.  MicroRNA profiling of human gastric cancer. , 2009, Molecular medicine reports.

[22]  Peter A. Jones,et al.  MicroRNAs: critical mediators of differentiation, development and disease. , 2009, Swiss medical weekly.

[23]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[24]  S. Cohen,et al.  microRNA functions. , 2007, Annual review of cell and developmental biology.

[25]  Yong Zhao,et al.  Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis , 2005, Nature.

[26]  V. Ambros The functions of animal microRNAs , 2004, Nature.

[27]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.

[28]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[29]  J. Massagué,et al.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus. , 2003, Cell.

[30]  A. Roberts,et al.  Role of transforming growth factor-beta signaling in cancer. , 2000, Journal of the National Cancer Institute.

[31]  Liliana Attisano,et al.  SARA, a FYVE Domain Protein that Recruits Smad2 to the TGFβ Receptor , 1998, Cell.

[32]  S. Markowitz,et al.  Tumor suppressor activity of the TGF-beta pathway in human cancers. , 1996, Cytokine & growth factor reviews.

[33]  D. Kingsley,et al.  The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. , 1994, Genes & development.

[34]  J. Garland The New England Journal of Medicine. , 1961, Canadian Medical Association journal.